Respiratory tract infections
The non-specific clinical presentation of respiratory infections poses a considerable challenge to the differential diagnosis of pathogens. What impact can a timely and accurate diagnosis have on patient management?
Accurate accessible influenza and RSV testing
The young and old are particularly vulnerable to respiratory infections. Influenza has been known to kill up to 650,000 people every year,1 while RSV is the leading cause of lower respiratory disease in children younger than 4 years of age; globally, nearly all children have been infected with RSV at least once, by age two.2 On the other end of the age continuum, RSV is also common in adults older than 65 and their risk of serious infection increases with age.3 Timely test results can help guide clinical decisions regarding treatment and patient isolation for infection control.
cobas® Influenza A/B & RSV delivers:
The growing menu of molecular POC assays together with this innovative, connected analyzer, forms the Roche total point-of-care PCR solution. Now, emergency rooms, primary care and other novel POC settings can reliably standardize and mobilize molecular testing, enhancing patient safety and satisfaction.
*Performance of the test was compared with an FDA-cleared, laboratory-based, multiplexed, real-time, reverse transcription PCR (RT-PCR) test across three targets.
CI=confidence intervals. LOD=limit of detection. TCID=tissue culture infective dose.
Patient suspected of influenza
Specimen collected to perform a rapid
influenza diagnostic test (RITD)
Negative result needs confirmation.
Risk of delayed treatment decisions.
Samples sent to the lab for PCR testing (4-24 hours)
Patient less likely to benefit from antiviral treatment
started >48 hours after symptom onset5
Patient suspected of RSV
Specimen collected to perform an RSV
rapid antigen diagnostic test (RADT)
Negative result still leave unanswered questions.
Risk of delayed treatment decisions.
Patient suspected of influenza or RSV
Specimen collected
Perform cobas® Influenza A/B & RSV test
(Definitive results in 20 minutes)
Rapidly test, triage, and treat your patients with the accuracy, simplicity, and security needed at the point of care.
Elevating care across your POC testing ecosystem
Respiratory tract infections
The non-specific clinical presentation of respiratory infections poses a considerable challenge to the differential diagnosis of pathogens. What impact can a timely and accurate diagnosis have on patient management?
Healthcare-associated infections (HAIs)
From prolonging institutional stays to creating long-term disability, healthcare-associated infections place a tremendous financial burden on health systems.
Antibiotic resistance and diagnostic testing
As mankind continues its widespread use of antibiotics, antimicrobial resistance will continue to pose a threat to the global healthcare system.
References